251
Participants
Start Date
December 31, 2005
Primary Completion Date
December 31, 2009
Study Completion Date
December 31, 2009
CP-675,206
15 mg/kg Q12W dosing regimen
Research Site, Westmead
Research Site, Waratah
Research Site, East Melbourne
Research Site, Woolloongabba
Research Site, Nedlands
Research Site, New York
Research Site, Berlin
Research Site, Buffalo
Research Site, Pittsburgh
Research Site, Bethlehem
Research Site, Milan
Research Site, Milan
Research Site, Milan
Research Site, Kiel
Research Site, Durham
Research Site, Madrid
Research Site, Pamplona
Research Site, Orlando
Research Site, Orlando
Research Site, Ocoee
Research Site, Nashville
Research Site, Louisville
Pfizer Investigational Site, Columbus
Research Site, Columbus
Research Site, Indianapolis
Research Site, Indianapolis
Research Site, Indianapolis
Research Site, Meldola, FC
Research Site, Zaragoza
Research Site, Madison
Research Site, Lille
Research Site, Frankfurt
Research Site, Chicago
Research Site, Tübingen
Research Site, Little Rock
Research Site, Fayetteville
Research Site, Bentonville
Research Site, Paris
Research Site, Aurora
Research Site, Salt Lake City
Research Site, Scottsdale
Research Site, Los Angeles
Research Site, Villejuif
Research Site, Federal Way
Research Site, Seattle
Research Site, Seattle
Research Site, Tacoma
Research Site, Lakewood
Research Site, Los Angeles
Research Site, Stamford
Research Site, Baltimore
Research Site, Boston
Research Site, Ann Arbor
Research Site, Chapel Hill
Research Site, Nashville
Research Site, Ciudad de Buenos Aires
Research Site, Hamilton
Research Site, Barcelona
Research Site, Truro
Research Site, Northwood
Research Site, Sutton
Research Site, Newcastle upon Tyne
Research Site, London
Research Site, Manchester
Research Site, Newcastle upon Tyne
Lead Sponsor
AstraZeneca
INDUSTRY